LOS ANGELES, Feb. 28, 2014 /PRNewswire/ -- Verde Media Group
Inc. (OTC: VMGI) has announced the formation of the Verde Media
Biotechnology Division ("VMBD").
The VMBD division will undertake the business of developing and
producing high value bio-products from renewable biomass. The focus
and criterion is to develop proprietary technologies with low risk
of scale-up utilizing low cost feedstock. After successful
production at demonstration scale such technologies and products
will be licensed and sold to third parties globally.
VMBD will initially focus on two high value products with an
over-lapping technology platform. First is the high density
microbial production of Omega-3 oil. The market for
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) Omega-3
products measured by global consumer spending on EPA/DHA fortified
products was $25.4 billion in 2011
for the six following categories: infant formula; fortified foods
and beverages; nutritional supplements; pharmaceuticals; clinical
nutrition; and pet food, treats and supplements. The projected
market value of EPA/ DHA Omega-3 products will reach $34.7 billion in 2016 with a continued
accelerated growth rate over the next 5 years.
Secondly, the technology division will develop platform
technologies for extracting highly purified forms of cannabis-based
phytocannabinoids products, including D9 tetrahydrocannabinol (THC)
and cannabidiol (CBD). VMBD will develop the derivative and
ester forms of THC for increase potency and their use in different
delivery systems, including sublingual, inhaled dosage forms and
blending with food products.
The initial core team consists of experienced scientists and
financial experts. Dr. Syed Hussain
Abidi, Ph.D in biotechnology, from Oxford University, will lead the VMBD division as
the Chief Executive Officer. Dr. Abidi has worked in the
chemical engineering school at MIT and
Harvard University and brings 10 years
of experience in organism development and fermentation. He invented
a microbial process of converting sugars to oil, similar to
vegetable derived oil, used in the biofuel industry that lead to a
series of high profile patents. Several of his patents have been
successfully licensed to biotech companies both in the US and
globally resulting in significant investment.
William Veve, President of Verde
Media Group, Inc. stated, "We will scale the technologies
developed, secure significant licence fees, and quickly bring
products to market. With the leadership and proven track
record of Dr. Abidi in biotech startups VMDB will be a substantial
revenue generator."
Syed Abidi, CEO of VMBD stated,
"The microbial production of high value edible oils represent an
exciting opportunity to "fill-in" the growing gap between
increasing demand and greatly diminishing supply of existing fish
derived omega-3 oils. The microbial-based omega-3 oils are
sustainable and unique in that they also meet the quality standards
for niche cosmetic and food applications. Our core platform
technology of production, extraction and purification of omega-3
oil will also be instrumental for the medical marijuana oil market-
where high degree of purification and sub-fractionation and product
derivation is required for human consumption."
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING
STATEMENTS
The results described herein cannot be guaranteed. This release
contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Statements in this news release other than statements of historical
fact are "forward-looking statements" that are based on current
expectations and assumptions.
SOURCE Verde Media Group, Inc.